Group 1 - The mayor emphasized the importance of integrating technological and industrial innovation to create new development advantages and accelerate the construction of a more innovative city [1] - Yao Gaoyuan highlighted the need for companies to seize opportunities in artificial intelligence, enhance innovation capabilities in niche markets, and achieve forward-looking technological layouts [1] - The focus is on improving collaborative innovation mechanisms among research institutions and enterprises to enhance industry data resource integration and promote the application of core technologies [1] Group 2 - Hangzhou Juhua Technology Co., Ltd. specializes in the research, production, and sales of energy IoT devices, providing services through an energy management cloud platform [2] - The mayor pointed out the necessity of supporting enterprises in boldly innovating across product services, business models, and management practices [2] - There is a call to establish a diversified investment system for technological innovation involving government, enterprises, universities, and research institutions to stimulate high-quality development [2]

人民财讯8月12日电，诚益通（300430）8月12日在互动平台表示，公司已确立"侵入式与非侵入式"双轨 并行的战略布局，在非侵入式严肃医疗赛道，公司目前主要将现有康复设备与脑机接口进行结合，升级 现有产品功能，并积极推进相关商业化落地；除医疗领域外，公司也在积极探索"非医疗"场景的应用， 包括教育、养老、健康等多个领域，其中，在教育领域，公司已推出面向专注力检测与训练的脑机接口 生物反馈系统。在侵入式领域，公司脑机接口技术研究验证中心与动物实验中心正在建设中，作为公司 在脑机接口领域的重要战略布局，两大中心将构建"基础研究—技术验证—成果转化"的完整创新链条。 ...

证券代码：688329 证券简称：艾隆科技 公告编号：2025-036 苏州艾隆科技股份有限公司 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 为积极响应上海证券交易所《关于开展沪市公司"提质增效重回报"专项行动 的倡议》，深入贯彻党的二十大和中央金融工作会议精神，落实国务院《关于进 一步提高上市公司质量的意见》要求，推动公司高质量发展和投资价值提升，保 护投资者尤其是中小投资者合法权益，助力资本市场健康发展，苏州艾隆科技股 份有限公司（以下简称"公司"）于 2025 年 5 月 21 日披露了 2025 年度"提质增效 重回报"专项行动方案。2025 年上半年，公司根据行动方案内容，积极开展和落 实各项工作，现将 2025 年上半年主要进展及成效情况报告如下： 一、聚焦主营业务，提升经营质量 但实现归属于母公司所有者的净利润-839.02 万元，较上年同期上升 55.47%。与 此同时，公司进一步落实预算管理工作，做好成本优化和费用管控，2025 年上 半年，公司主营业务成本 6,656.78 万元，同比下降 5.68 ...

Group 1 - The forum "Digital Intelligence as a Bridge: Medical Engineering Integration" was held in Shenzhen, marking a significant step in Shenzhen's health technology innovation and the transition from "passive medical care" to "active health" strategy [1][3] - The event was organized by the Shenzhen Hospital Association and included the establishment of the "Medical Engineering Integration Active Health Research Institute" and the "CHART Alliance" in the Guangdong-Hong Kong-Macao Greater Bay Area, which are key strategic outcomes of the forum [1][2] - The Medical Engineering Integration Active Health Research Institute aims to create a comprehensive active health technology engine and lead the formulation of national and industry standards to shift the medical model towards a "people-centered health" approach [1][2] Group 2 - The CHART Alliance focuses on comprehensive management of vascular diseases and aims to build a full-service system from prevention to rehabilitation, accelerating the application and innovation of cardiovascular imaging and AI technology in the Greater Bay Area [2] - The establishment of these platforms is a practical response to national health initiatives, gathering top expertise to drive the transition from "passive medical care" to "active health" and injecting innovation into the health sector [2] - The forum featured three thematic roundtable discussions involving 16 leading experts, addressing key topics such as AI imaging diagnosis, interdisciplinary talent cultivation, and the application of new cardiovascular imaging technologies [2][3] Group 3 - The successful hosting of the forum through innovative mechanisms and strategic layouts has established a high-end ecosystem for medical engineering integration, providing a replicable practice model for the "Healthy China 2030" and "Digital Shenzhen" strategies [3] - This event signifies a new phase of scaled, standardized, and systematic development in Shenzhen's medical engineering integration efforts, laying a solid foundation for creating a global health innovation hub in the Greater Bay Area [3]

Core Viewpoint - The company has signed an ecological cooperation agreement with Shenzhen Computing Science Research Institute to enhance its AI medical model business through collaboration in data quality and analysis [1][2] Group 1: Strategic Partnership - The partnership aims to leverage each party's resources, talent, and technological advantages for deep cooperation in database, data quality, and data analysis [1] - The agreement will integrate cutting-edge technologies developed by the research institute in database systems, data quality systems, and data analysis systems [2] Group 2: AI Medical Model Development - The company is focusing on the development of AI medical models, which require high-quality, secure, and available medical big data as core support [1] - The collaboration will enable the company to provide a full-process service covering data cleaning, intelligent analysis, and customized model training for various clients, including medical institutions and government departments [2] Group 3: Competitive Advantage - By utilizing high-quality data and precise analytical capabilities, the company aims to accelerate the optimization and commercialization of its AI medical models [2] - This strategic move is expected to strengthen the company's core competitiveness in the AI medical sector [2]

Core Viewpoint - New Open Source's stock price has shown a positive trend, with a notable increase on August 11, 2025, amidst developments in the medical technology sector that could impact related companies [1] Company Summary - New Open Source's stock price reached 17.65 yuan on August 11, 2025, marking a 1.73% increase from the previous trading day [1] - The opening price for the day was 17.44 yuan, with a high of 17.97 yuan and a low of 17.36 yuan, resulting in a trading volume of 2.97 billion yuan [1] - The company's main business areas include chemical products, CAR-T cell therapy, and solid-state batteries, with operations in the Henan region and involvement in disinfectant concepts [1] Industry Summary - Baichuan Intelligent released the Baichuan-M2 medical enhancement model on August 11, 2025, which reportedly surpasses OpenAI's latest open-source model in medical capabilities, potentially affecting companies in the medical technology sector [1] - On the funding side, New Open Source experienced a net outflow of 1.89 million yuan on August 11, with a cumulative net outflow of 71.59 million yuan over the past five days [1]

Core Insights - The article highlights the significant value of high-purity platinum wire (PT999), which has a recovery price of 292 RMB per gram, surpassing the average recovery price of gold at 289.67 RMB per gram as of August 2025 [1][7]. Application Scenarios - High-purity platinum wire is essential in various industrial sectors, including petrochemicals, where it serves as a core component of catalysts, significantly enhancing crude oil conversion rates and generating billions in economic value annually [2][6]. - In automotive exhaust systems, platinum wire plays a crucial role in converting harmful gases into harmless substances, with each vehicle meeting National VI standards containing 3-5 grams of platinum [2]. - The precision electronics field relies on platinum wire for high-precision resistors and thermal components, maintaining stable performance across extreme temperatures [6]. - In the renewable energy sector, platinum wire is vital for hydrogen fuel cells, with current vehicles consuming approximately 30 grams of platinum, over 60% of which is high-purity platinum wire [6]. Recovery Value - The recovery value of platinum wire is driven by its scarcity and irreplaceability, with platinum's crustal abundance being only 1/20th that of gold and extraction costs exceeding those of gold by over three times [7]. - As of August 2025, the recovery prices for different purities of platinum wire show a clear gradient: PT999 at 292 RMB/g, PT990 at 289 RMB/g, and PT950 at 277 RMB/g, reflecting the direct correlation with platinum content [7]. Price Mechanism - The formation of recovery prices is influenced by multiple factors, including international market fluctuations, with platinum prices peaking at 350 RMB/g due to increased demand from hydrogen fuel cells before stabilizing between 260-300 RMB/g [8][9]. - Recovery channels vary significantly, with banks typically offering lower prices than market rates, and regulatory support for compliant recovery businesses leading to higher quotes compared to the black market [8][10]. - Technological innovations, such as microwave pre-treatment, have improved recovery rates from 85% to 98%, significantly reducing processing costs and enhancing profitability [9]. Maximizing Value - Companies and individuals holding platinum wire waste should focus on three key aspects for optimal monetization: accurate purity detection, choosing legitimate recovery channels, and timing the market effectively [10]. - The article emphasizes the importance of monitoring government policies and market trends to capitalize on high price points, suggesting a phased selling strategy for larger holdings to mitigate market volatility [10]. Conclusion - The extensive applications of platinum wire across industries underscore its recovery value, which is further enhanced by sustainable practices and technological advancements, contributing to both economic returns and resource sustainability [11].

证券代码：603122 证券简称：合富中国 公告编号：临 2025-033 合富（中国）医疗科技股份有限公司 《证券日报》和上海证券交易所网站（http://www.sse.com.cn）上披露本公司 营业收入。本简报为初步核算数据，未经会计师事务所审计或审阅，最终数据 以公司定期报告为准，敬请投资者注意投资风险。 公司 2025 年 1-7 月合并营业收入人民币 42,512.74 万元，较去年同期下降 特此公告。 合富（中国）医疗科技股份有限公司董事会 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 合富（中国）医疗科技股份有限公司（以下简称"公司"）之间接控股股东 合富医疗控股股份有限公司（以下简称"合富控股"）为台湾地区证券柜台买 卖中心上柜公司，合富控股需按照台湾证券交易所相关规定，每月披露营业收 入数据。为使 A 股投资者能够及时了解公司的经营情况，本公司亦同步在上海 证券交易所指定的信息披露媒体《上海证券报》、《中国证券报》、《证券时报》、 ...

□ 本报记者李凯通讯员麒轩 暑假期间，各大医院里来矫治脊柱侧弯的孩子明显增加。国家疾控中心、国家儿童青少年脊柱侧弯防控 工作组等机构的研究数据显示，脊柱侧弯已成为我国中小学生继肥胖、近视后的第三大健康杀手，发生 率为1%—3%。 一方面是呈逐年上升趋势的发病率，另一方面是传统诊疗体系的短板和痛点——专业筛查资源少导致等 待周期长、缺乏专用3D打印设备、定制化矫形支具动辄上万元的费用更让许多家庭望而却步。面对这 一现实困境，南京麒麟科创园一家新成立的科技企业——南京云兮生物科技有限公司正用AI技术构建 全新解决方案，为青少年足脊矫正带来开创性新产品。 "脊柱侧弯，一个看似不起眼却可能影响孩子一生的健康隐患。最新的人工智能技术和新材料有望解决 这个难题，但目前市面上还缺乏这样的破局者，而这也是团队创业的出发点。"云兮生物运营总监邵漠 宇介绍。 "既提升个性化定制的设计制造效率，又提高矫正精准度。"邵漠宇表示，"矫形器本身也做了智能化开 发，相比传统的矫形器，我们的矫形器适配后可以智能感知力学矫正状况及患者的呼吸波、心率等生理 指标，实现力学矫正状况的实时监测，这样患者有没有按时佩戴、佩戴是否规范，我们和家长都可以 ...

Core Insights - The article emphasizes the importance of integrating clinical, capital, channel, and regulatory aspects to drive high-quality development in the medical technology sector, particularly focusing on Chinese innovation in the global context [1]. Group 1: Medical Ecosystem and Innovation - The Shanghai Jiao Tong University School of Medicine is highlighted as a key player in fostering a valuable medical and health ecosystem, with 13 affiliated hospitals and 21 academicians providing strong academic support and clinical resources for entrepreneurs [9]. - The establishment of the first incubation fund by the Medical Future Alumni Association aims to lead alumni in early investments in medical technology, facilitating earlier market entry [9]. - The article discusses the unique "Value Engine Methodology" that promotes collaboration between academia and industry, enhancing strategic thinking, innovation capabilities, and leadership skills among entrepreneurs [9][10]. Group 2: Educational Programs and Curriculum - The curriculum is designed to address trends, challenges, and innovations in the medical industry, helping participants understand the development trajectory and strategic layout of the sector [11]. - The program emphasizes the cultivation of entrepreneurial thinking, enabling participants to formulate growth strategies and make informed decisions in uncertain market conditions [12]. - Various modules cover topics such as strategic customization, value discovery, and innovative thinking, aimed at equipping participants with the necessary skills for future challenges in the medical field [16]. Group 3: Industry Trends and Future Directions - The article identifies key trends in the medical industry, including the aging economy, consumer healthcare, and the integration of technology in healthcare services [17][19]. - It discusses the importance of understanding the silver economy's value chain, including sectors like elderly care, rehabilitation, and entertainment, as well as the emerging business models in consumer healthcare [19]. - The integration of new technologies such as artificial intelligence, big data, and wearable devices is highlighted as a significant trend shaping the future of the medical industry [19].